Lynx1 Capital Management LP

Insider Reports History

Location
Dorado
Signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynx1 Capital Management LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. 10%+ Owner Common stock, $0.0001 par value per share 8,963,500 $75,297,881 $8.40 28 Oct 2025 Indirect
TScan Therapeutics, Inc. 10%+ Owner Pre-funded Warrant (right to buy) 7,500,000 $30,000,000 $4.00 26 Dec 2024 Indirect
Neuphoria Therapeutics Inc. 10%+ Owner Common stock, $0.00001 par value per share 875,328 $10,381,390 $11.86 21 Oct 2025 Indirect
TScan Therapeutics, Inc. 10%+ Owner Common Stock 8,019,148 $7,208,412 $0.8989 23 Dec 2025 Indirect
Passage BIO, Inc. 10%+ Owner Common Stock 623,704 $4,359,379 $6.99 15 Sep 2025 Indirect

Insider Reports Filed by Lynx1 Capital Management LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRX TScan Therapeutics, Inc. 19 Dec 2025 3 +$145,526 4 10%+ Owner 23 Dec 2025, 18:17
CGEM Cullinan Therapeutics, Inc. 28 Oct 2025 1 +$1,391,686 4 10%+ Owner 30 Oct 2025, 17:13
NEUP Neuphoria Therapeutics Inc. 21 Oct 2025 1 +$3,283,108 4 10%+ Owner 23 Oct 2025, 19:49
NEUP Neuphoria Therapeutics Inc. 21 Oct 2025 0 $0 3 10%+ Owner 23 Oct 2025, 19:47
CGEM Cullinan Therapeutics, Inc. 14 Oct 2025 4 +$2,103,912 4 10%+ Owner 21 Oct 2025, 19:00
CGEM Cullinan Therapeutics, Inc. 08 Oct 2025 3 +$9,826,941 4 10%+ Owner 10 Oct 2025, 18:58
CGEM Cullinan Therapeutics, Inc. 08 Oct 2025 0 $0 3 10%+ Owner 10 Oct 2025, 18:56
PASG Passage BIO, Inc. 11 Sep 2025 3 +$223,735 4 10%+ Owner 15 Sep 2025, 20:05
PASG Passage BIO, Inc. 22 Jul 2025 3 +$733,826 4 10%+ Owner 24 Jul 2025, 18:12
TCRX TScan Therapeutics, Inc. 19 May 2025 2 +$3,106,553 4 10%+ Owner 21 May 2025, 16:49
PASG Passage BIO, Inc. 27 Dec 2024 1 +$241,038 4 10%+ Owner 31 Dec 2024, 16:05
TCRX TScan Therapeutics, Inc. 26 Dec 2024 1 +$30,000,000 4 10%+ Owner 30 Dec 2024, 16:15
TCRX TScan Therapeutics, Inc. 12 Dec 2024 2 +$385,769 4 10%+ Owner 16 Dec 2024, 16:26
PASG Passage BIO, Inc. 25 Nov 2024 3 +$284,520 4 10%+ Owner 27 Nov 2024, 18:11
TCRX TScan Therapeutics, Inc. 15 Nov 2024 1 +$4,114 4 10%+ Owner 19 Nov 2024, 16:26
PASG Passage BIO, Inc. 07 Aug 2024 0 $0 3 10%+ Owner 09 Aug 2024, 17:11
TCRX TScan Therapeutics, Inc. 19 Apr 2024 1 +$35,649,500 4 10%+ Owner 23 Apr 2024, 16:15
TCRX TScan Therapeutics, Inc. 31 May 2023 3 -$63,952 4 10%+ Owner 02 Jun 2023, 17:35
TCRX TScan Therapeutics, Inc. 31 May 2023 0 $0 3 10%+ Owner 02 Jun 2023, 17:33